Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × Perindopril × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Women With Breast Cancer 1 Heart Failure 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Carvedilol 2 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Trastuzumab 1 Specimen Handling 1 Secondary Prevention 1 Perindopril 1 Ogivri 1 Metoprolol 1 Exercise 1 Electronic Health Records 1 Echocardiography 1 Carnitine 1 Bisoprolol 1 Adrenergic beta-Antagonists 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01016886 2016-02-09

MANTICORE

AHS Cancer Control Alberta

Phase 1/2 Unknown

Breast Neoplasms, Heart Failure, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡